S. Smits

Comparative Seroprevalence and Immunogenicity of Six Rare Serotype Recombinant Adenovirus Vaccine Vectors from Subgroups B and D

K. Mansfield, M. Havenga, A. Lemckert, 2007, Journal of Virology.

Enzyme-linked immunosorbent assay using monoclonal antibodies for identification of mycobacteria from early cultures

K. Polman, S. Maselle, P. Peerbooms, 1991, Journal of clinical microbiology.

Generation of a novel replication-incompetent adenoviral vector derived from human adenovirus type 49: manufacture on PER.C6 cells, tropism and immunogenicity.

B. Berkhout, P. Quax, M. Havenga, 2006, The Journal of general virology.

High‐Level Expression of Recombinant IgG in the Human Cell Line PER.C6

T. Logtenberg, D. Opstelten, A. Bout, 2003, Biotechnology progress.

Serum‐free transient protein production system based on adenoviral vector and PER.C6 technology: High yield and preserved bioactivity†

G. Hateboer, M. Havenga, R. Vogels, 2007, Biotechnology and bioengineering.

Molecular cytogenetic characterization by combined COBRA-FISH and fiber-FISH: application to PER.C6 cells.

H. Tanke, J. Wiegant, A. Raap, 2004, BioTechniques.

Molecular cytogenetic characterization by combined COBRA-FISH and fiber-FISH : application to PER . C 6 ® cells

H. Tanke, J. Wiegant, A. Raap, 2022 .